Published in Blood Weekly, September 10th, 2009
The session will feature a panel of distinguished experts representing government agencies and private sector firms that deal with SBIR and STTR funding. Panelists include Greg Milman, Ph.D. from the National Institute of Allergies and Infectious Diseases, Ali Andalibi, Ph.D. from the National Cancer Institute and David Hood of the US Army. In addition, a separate panel of life science industry...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.